Skip to content

Cognitive Reserve as a Stratification Factor for Cognitive Impairment and Disease Progression in Major Depressive Disorder.

Sep 2026 · Psychotherapy and Psychosomatics · pp. 1 · 0 citations
Medicine

TL;DR

The moderating effect of CR on the brain network-cognition association provides a neurobiological rationale for this vulnerability and supports incorporating CR into routine clinical assessment to guide risk stratification and personalized treatment planning.

View source

Similar papers

Review Aug 2026

Advances in the Treatment of Cognitive Impairment in Major Depressive Disorder: Innovations and Research Challenges

The neurobiological basis of cognitive impairment in MDD is explored, key biomarkers associated with these deficits are identified, and their implications for diagnosis, prognosis, and therapeutic intervention are discussed.

Akansha Thakur, Parag Jain, M. Sharma et al. · 0 citations
Open access Sep 2026

674. Cognitive and neurobiological indicators of risk and prognosis in mood disorders

Abstract Background Mood disorders are major contributors to the global burden of disease. There is a critical need for reliable markers that can identify individuals at elevated risk for developing mood disorders and predict poor prognosis among those already affected, in order to guide personalized interventions. Aim...

A. Sankar, B. Ozenne, V. Dam et al. · 0 citations
Sep 2026

Treating depression predicts cognitive improvement in Mild Cognitive Impairment: a 1-year prospective cohort study.

BACKGROUND Depression frequently coexists with Mild Cognitive Impairment (MCI) and may influence its clinical trajectory, but the effect of treating depression on cognitive outcomes remains unclear. OBJECTIVE To evaluate whether treating depression is associated with distinct cognitive trajectories. METHODS This pr...

Valentina Baldini, Greta Martinelli, D. De Ronchi et al. · 0 citations
Open access Aug 2026

Baseline cortical structural features are associated with depressive and cognitive improvement in major depressive disorder

Major depressive disorder (MDD) exhibits substantial clinical and neurobiological heterogeneity, along with marked variability in treatment response, underscoring the need for objective neuroimaging markers to inform personalized interventions. Twenty-two patients with MDD and twenty-one age- and sex-mat...

Yingna Li, Shuping Tian, Siyan Zan et al. · 0 citations
Open access Sep 2026

529. **Rafaelsen Award Presentation** Cognitive function and the risk of later onset of depression in healthy individuals: a 10-year longitudinal study

Abstract Background Cognitive impairments are common in individuals with depression, but their role in the etiology of the disorder remains unclear. Aims & Objectives In this 10-year longitudinal study, we tested whether cognitive function is associated with a risk for developing future first-episode depression in indi...

A. Sankar, B. Ozenne, V. Dam et al. · 0 citations
Open access Sep 2026

Prevalence and associated factors of cognitive impairment in patients with major depressive disorder: a cross-sectional study in Vietnam.

OBJECTIVE Cognitive impairment is increasingly recognised as a core feature of major depressive disorder (MDD), but data from low- and middle-income countries, including Vietnam, remain scarce. This study examined the prevalence of cognitive impairment among patients with MDD and identified associated factors. METHOD...

Hung The Nguyen, Nhung Thi Hong Nguyen, Phuc Truong Vinh Le et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.